Thrivent Financial for Lutherans’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,243
| Closed | -$220K | – | 2552 |
|
|
2023
Q1 | $220K | Sell |
1,243
-43
| -3% | -$7.61K | ﹤0.01% | 2364 |
|
|
2022
Q4 | $497K | Sell |
1,286
-10
| -0.8% | -$3.87K | ﹤0.01% | 2122 |
|
|
2022
Q3 | $437K | Buy |
1,296
+141
| +12% | +$47.5K | ﹤0.01% | 2119 |
|
|
2022
Q2 | $380K | Buy |
1,155
+208
| +22% | +$68.4K | ﹤0.01% | 2194 |
|
|
2022
Q1 | $414K | Sell |
947
-8
| -0.8% | -$3.5K | ﹤0.01% | 2259 |
|
|
2021
Q4 | $419K | Buy |
955
+10
| +1% | +$4.39K | ﹤0.01% | 2241 |
|
|
2021
Q3 | $525K | Sell |
945
-32
| -3% | -$17.8K | ﹤0.01% | 2160 |
|
|
2021
Q2 | $502K | Buy |
+977
| New | +$502K | ﹤0.01% | 2179 |
|